Liraglutide is associated with a slightly higher risk of nausea, while Semaglutide may present a more favorable safety profile in some patients
2.5 mg, 5 mg, 10 mg, 15 mg *This estimate derives from Eli Lillys SURMOUNT-1 clinical trial results which showed 20% average weight loss over 72 weeks among people that utilized a maximum tolerated dose of 10 mg or 15 mg once-weekly
Semaglutide also modulates appetite suppression, energy expenditure and satiety signaling through its binding to GLP-1R in the hypothalamus (e.g., arcuate nucleus) [79]
This framework illustrates that real cost is determined by multiple performance factors rather than price alone
Very low-calorie diets (below 800 kcal/day) should only be undertaken under medical supervision, in line with NICE guidance on obesity management (NICE CG189 and successor guidance)
Real-Life Scenarios: Why You Might Choose This Pair Think about your typical week